Skip to main content
logo
Nexalis Therapeutics Limited (ASX:NX1)
Australia flag Australia · Delayed Price · Currency is AUD
0.0110
0.00 (0.00%)
At close: Jul 23, 2026

Nexalis Therapeutics Financials Overview

Millions AUD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.990.990.41.20.020.18
Revenue Growth
18.29%145.50%-66.63%4755.02%-86.35%721.35%
Gross Profit
0.990.990.41.20.020.07
Operating Income
-1.49-1.49-1.28-1.42-1.95-1.11
Net Income
-1.62-1.62-1.21-1.44-1.93-1.11
Earnings Per Share
-0.01-0.01-0.01-0.01-0.01-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.440.440.190.722.132.8
Total Debt
0.740.740.030.56--
Net Cash (Debt)
-0.3-0.30.160.162.132.8
Net Cash Growth
--3.41%-92.71%-23.90%63.04%
Net Cash Per Share
-0.00-0.000.000.000.010.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.89-0.89-0.37-1.96-1.85-1.15
Capital Expenditures
------0.01
Free Cash Flow
-0.89-0.89-0.37-1.96-1.85-1.16
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%36.59%
Operating Margin
-150.85%-150.85%-318.39%-118.22%-7879.43%-611.57%
Pretax Margin
-164.10%-164.10%-300.98%-119.87%-7770.36%-611.38%
Profit Margin
-164.10%-164.10%-300.98%-119.87%-7770.36%-611.38%
FCF Margin
-90.04%-90.04%-91.78%-162.94%-7444.75%-638.32%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.825.8218.594.57453.0683.43